Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Purpose: The aim of the F2 study was to verify whether a prospective collection of data would enable the development of a more accurate prognostic index for follicular lymphoma (FL) by using parameters which could not be retrospectively studied before, and by choosing progression-free survival (PFS) as principal end point. Patients and Methods: Between January 2003 and May 2005, 1,093 patients with a newly diagnosed FL were registered and 942 individuals receiving antilymphoma therapy were selected as the study population. The variables we used for score definition were selected by means of bootstrap resampling procedures on 832 patients with complete data. Procedures to select the model that would minimize errors were also performed. Results: After a median follow-up of 38 months, 261 events for PFS evaluation were recorded. β2-microglobulin higher than the upper limit of normal, longest diameter of the largest involved node longer than 6 cm, bone marrow involvement, hemoglobin level lower than 12 g/dL, and age older than 60 years were factors independently predictive for PFS. Using these variables, a prognostic model was devised to identify three groups at different levels of risk. The 3-year PFS rate was 91%, 69%, and 51% for patients at low, intermediate, and high risk, respectively (log-rank = 64.6; P < .00001). The 3-year survival rate was 99%, 96%, and 84% for patients at low, intermediate, and high risk, respectively (P < .0001). Conclusion: Follicular Lymphoma International Prognostic Index 2 is a simple prognostic index based on easily available clinical data and may represent a promising new tool for the identification of patients with FL at different risk in the era of immunochemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Self-citationEvaluating the Yield of Medical Tests
Harrell, F. E. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320430047030 · Cited by 3,490
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
Regression modelling strategies for improved prognostic prediction
Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,798
Dave, S. S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041869 · Cited by 1,418
Follicular lymphoma international prognostic index
Solal-Celigny, P. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0036-3 · Cited by 1,339
Marcus, R. (2005) · Blood · doi:10.1182/blood-2004-08-3175 · Cited by 967
Follicular Lymphoma International Prognostic Index
Solal-Celigny, P. (2004) · Blood · doi:10.1182/blood-2003-12-4434 · Cited by 626
Gallamini, A. (2004) · Blood · doi:10.1182/blood-2003-09-3080 · Cited by 598
van Oers, M. H. J., Klasa, R., Marcus, R. E., Wolf, M., Kimby, E., Gascoyne, R. D., Jack, A., van't Veer, M., Vranovsky, A., Holte, H., et al. (2006) · Blood · doi:10.1182/blood-2006-05-021113 · Cited by 592
Farinha, P., Masoudi, H., Skinnider, B. F., Shumansky, K., Spinelli, J. J., Gill, K., Klasa, R., Voss, N., Connors, J. M., & Gascoyne, R. D. (2005) · Blood · doi:10.1182/blood-2005-04-1565 · Cited by 461
Natural history of and therapy for the indolent non-Hodgkin's lymphomas.
Horning, S. J. (1993) · PubMed · Cited by 421
Follicular Lymphoma in the United States: First Report of the National LymphoCare Study
Friedberg, J. W., Taylor, M. D., Cerhan, J. R., Flowers, C. R., Dillon, H., Farber, C. M., Rogers, E. S., Hainsworth, J. D., Wong, E. K., Vose, J. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1495 · Cited by 294
Glas, A. M. (2005) · Blood · doi:10.1182/blood-2004-06-2298 · Cited by 225
A strategy for modelling the effect of a continuous covariate in medicine and epidemiology
Royston, P. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20000730)19:14<1831::aid-sim502>3.0.co;2-1 · Cited by 219
Federico, M., Vitolo, U., Zinzani, P. L., et al. (2000) · PubMed · Cited by 183
Self-citationBataille, R., Durie, B. G. M., & Grenierj, J. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.tb02158.x · Cited by 177
The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas
López‐Guillermo, A., Cabanillas, F., McLaughlin, P. J., Smith, T., Hagemeister, F. B., Rodriguez, M. A., Romaguera, J. E., Younes, A., Sarris, A. H., Preti, H. A., et al. (1998) · Blood · doi:10.1182/blood.v91.8.2955.2955_2955_2960 · Cited by 162
Self-citationMultivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.
Romaguera, J. E., McLaughlin, P. J., North, L., Dixon, D. O., Silvermintz, K. B., Garnsey, L., Velasquez, W. S., Hagemeister, F. B., & Cabanillas, F. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.5.762 · Cited by 146
Self-citationPrognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma
Litam, P. P., Swan, F., Cabanillas, F., Tucker, S. L., McLaughlin, P. J., Hagemeister, F. B., Rodriguez, M. A., & Velasquez, W. S. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-10-855 · Cited by 100
Self-citationThe identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma
Leonard, R. C., Hayward, R. L., Prescott, R. J., et al. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058044 · Cited by 81
A Systematic Overview of Chemotherapy Effects in Indolent Non-Hodgkin's Lymphoma
Brandt, L., Kimby, E. K., Nygren, P., & Glimelius, B. L. G. (2001) · Acta Oncologica · doi:10.1080/02841860118520 · Cited by 39
Investigation about a screening step in model selection
Sauerbrei, W., Holländer, N., & Buchholz, A. (2008) · Statistics and Computing · doi:10.1007/s11222-007-9048-5 · Cited by 21
Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665
Casulo, C., Byrtek, M., Dawson, K. L., Zhou, X., Farber, C. M., Flowers, C. R., Hainsworth, J. D., Maurer, M. J., Cerhan, J. R., Link, B. K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7534 · Cited by 850
Dreyling, M., Campo, E., Hermine, O., Jerkeman, M., Le Gouill, S., Rule, S., Shpilberg, O., Walewski, J., & Ladetto, M. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx223 · Cited by 741
Pastore, A., Jurinovic, V., Kridel, R., Hoster, E., Staiger, A. M., Szczepanowski, M., Pott, C., Kopp, N., Murakami, M., Horn, H., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00169-2 · Cited by 618
Metadata
- Authors
- Federico, M., Bellei, M., Marcheselli, L., Luminari, S., Lopez-Guillermo, A., Vitolo, U., Pro, B., Pileri, S., Pulsoni, A., Soubeyran, P., Cortelazzo, S., Martinelli, G., Martelli, M., Rigacci, L., Arcaini, L., Di Raimondo, F., Merli, F., Sabattini, E., McLaughlin, P., & Solal-Céligny, P.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-09-20
- Volume
- 27
- Issue
- 27
- Pages
- 4555-4562
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1970648523
- Cited by
- 751
- References
- 26
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.